ASMPT (00522.HK) -2.200 (-2.140%) Short selling $5.61M; Ratio 11.832% 's 3Q25 results missed both the expectations of BOCI and the market, primarily due to one-off factory shutdown costs, unfavorable product mix and higher operating expenses, according to BOCI's research report. However, the management remained optimistic about 2026 and 2027, mainly benefiting from the Company's technological leadership in TCB and other advanced packaging (AP) solutions, as well as the recovery in mainstream application demand driven by AI and the growth of China's NEV.Related News M Stanley Selects 26 Chinese 'Best Business Models' Stocks (Table)The broker lowered its 2025-2027 earnings forecasts for ASMPT by 84%/ 21%/ 17% each to reflect a slower-than-expected recovery in gross profit margins. Nevertheless, with a clearer recovery outlook for SMT and mainstream semiconductor (SEMI) businesses and AP momentum driven by the continued incline in global AI capital expenditure, the broker kept rating at Buy, and raised its target price from $80 to $98. (HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)
AASTOCKS Financial News